We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.39% |
| 2 | Technology | 14.48% |
| 3 | Consumer Discretionary | 13.41% |
| 4 | Healthcare | 10.59% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Acuity Brands
AYI
$9.88B
| $5.77M | 0.01% |
48,044
+2,836
| +6% | +$353K |
|
602
Xylem
XYL
$28.5B
| $5.71M | 0.01% |
72,227
+25,539
| +55% | +$1.86M |
|
603
Teleflex
TFX
$5.85B
| $5.64M | 0.01% |
18,656
+16,070
| +621% | +$4.48M |
|
|
CHN
604
DELISTED
China Fund
CHN
| $5.57M | 0.01% |
273,263
-187,636
| -41% | -$3.58M |
|
|
INXN
605
DELISTED
Interxion Holding N.V.
INXN
| $5.56M | 0.01% |
83,377
-3,811
| -4% | -$236K |
|
606
Clearway Energy Class C
CWEN
$5B
| $5.56M | 0.01% |
368,000
-20,200
| -5% | -$303K |
|
607
Henry Schein
HSIC
$9.74B
| $5.54M | 0.01% |
92,085
+3,796
| +4% | +$229K |
|
608
Equitable Holdings
EQH
$13.1B
| $5.53M | 0.01% |
274,298
+261,714
| +2,080% | +$5M |
|
609
Universal Health Services
UHS
$9.43B
| $5.51M | 0.01% |
41,218
-55,750
| -57% | -$7.34M |
|
|
ETFC
610
DELISTED
E*Trade Financial Corporation
ETFC
| $5.51M | 0.01% |
118,745
+35,113
| +42% | +$1.67M |
|
611
Atmos Energy
ATO
$29.9B
| $5.51M | 0.01% |
53,503
+40,370
| +307% | +$3.93M |
|
612
Blackstone Mortgage Trust
BXMT
$2.82B
| $5.5M | 0.01% |
158,984
| – | – |
|
613
Gartner
IT
$9.41B
| $5.49M | 0.01% |
36,166
+12,545
| +53% | +$1.74M |
|
614
Franklin Resources
BEN
$16.9B
| $5.48M | 0.01% |
165,392
+43,576
| +36% | +$1.38M |
|
615
Alliant Energy
LNT
$19.4B
| $5.47M | 0.01% |
115,981
+29,328
| +34% | +$1.31M |
|
616
PG&E
PCG
$47.8B
| $5.45M | 0.01% |
306,044
-158,976
| -34% | -$2.57M |
|
617
Sabre
SABR
$656M
| $5.42M | 0.01% |
253,169
+31,033
| +14% | +$689K |
|
618
Hormel Foods
HRL
$13.9B
| $5.42M | 0.01% |
121,001
+35,044
| +41% | +$1.5M |
|
619
Howmet Aerospace
HWM
$116B
| $5.4M | 0.01% |
368,533
+79,143
| +27% | +$1.13M |
|
|
JWN
620
DELISTED
Nordstrom
JWN
| $5.33M | 0.01% |
120,074
+19,337
| +19% | +$882K |
|
621
The Mosaic Company
MOS
$7.09B
| $5.28M | 0.01% |
193,275
+16,535
| +9% | +$504K |
|
622
United Therapeutics
UTHR
$26.3B
| $5.25M | 0.01% |
44,730
| – | – |
|
623
Packaging Corp of America
PKG
$22.7B
| $5.24M | 0.01% |
52,699
+28,093
| +114% | +$2.67M |
|
624
NiSource
NI
$22.4B
| $5.2M | 0.01% |
181,279
+46,788
| +35% | +$1.26M |
|
625
Dentsply Sirona
XRAY
$2.59B
| $5.18M | 0.01% |
104,551
+30,039
| +40% | +$1.32M |
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.